Shionogi Financial Statements From 2010 to 2024
| SGIOF Stock | USD 14.17 0.07 0.50% |
Check Shionogi financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shionogi's main balance sheet or income statement drivers, such as , as well as many indicators such as . Shionogi financial statements analysis is a perfect complement when working with Shionogi Valuation or Volatility modules.
Shionogi |
Shionogi Co Company Return On Equity Analysis
Shionogi's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Shionogi Return On Equity | 0.2 |
Most of Shionogi's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Shionogi Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Shionogi Co has a Return On Equity of 0.2014. This is 100.84% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 164.97% lower than that of the firm.
Shionogi Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Shionogi's current stock value. Our valuation model uses many indicators to compare Shionogi value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Shionogi competition to find correlations between indicators driving Shionogi's intrinsic value. More Info.Shionogi Co is rated below average in return on equity category among its peers. It is currently regarded as top stock in return on asset category among its peers reporting about 0.53 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Shionogi Co is roughly 1.89 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Shionogi's earnings, one of the primary drivers of an investment's value.About Shionogi Financial Statements
Shionogi stakeholders use historical fundamental indicators, such as Shionogi's revenue or net income, to determine how well the company is positioned to perform in the future. Although Shionogi investors may analyze each financial statement separately, they are all interrelated. For example, changes in Shionogi's assets and liabilities are reflected in the revenues and expenses on Shionogi's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Shionogi Co. Please read more on our technical analysis and fundamental analysis pages.
Shionogi Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. Shionogi Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan. Shionogi operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5693 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Shionogi Pink Sheet
Shionogi financial ratios help investors to determine whether Shionogi Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shionogi with respect to the benefits of owning Shionogi security.